Skip to main content
Watch Insiders
LGND filings

Corporate insider profile

Jason Haas Filing Activity

Latest reported as Corporate insider of LIGAND PHARMACEUTICALS INC (LGND).

Purchase filings
1
Reported companies
2
Net open-market value
-$1,631,320.47
Latest transaction
Jun 12, 2026

Affiliated corporations

Reported company relationships

LGNDLatest reported

LIGAND PHARMACEUTICALS INC

Corporate insider

ODTXPrior filing

Odyssey Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 12, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale6,461$255.58$1,651,320
May 8, 2026Odyssey Therapeutics, Inc. (ODTX)Chief Financial OfficerOpen Market Purchase1,000$20.00$20,000